Assessment of Thyroid Dysfunction in Patients Undergoing Haemodialysis at Sohag University Hospital

Launched by SOHAG UNIVERSITY · Jun 13, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how thyroid problems affect patients who are on hemodialysis, a treatment for those with severe kidney disease. Thyroid dysfunction is common in these patients, affecting anywhere from 20% to 60% of them, and can lead to serious health issues like heart disease and anemia. The study aims to understand the connection between kidney disease and thyroid issues better, so doctors can find ways to manage and improve the health of people undergoing dialysis.

To participate in this trial, you need to be an adult over 18 years old who has been on regular hemodialysis for at least three months and has end-stage renal disease (ESRD). However, you cannot join if you have a history of thyroid disease, have recently received treatment for thyroid issues, or have certain other health conditions that could affect the study results. If you are eligible, you can expect to undergo assessments to check your thyroid function and help researchers gather important information that could lead to better care for dialysis patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 years and older.
• • Patients diagnosed with end-stage renal disease (ESRD) on regular hemodialysis for at least 3 months.
• Exclusion Criteria:
• • Known Thyroid Disorders: Patients with a history of thyroid disease (e.g., hypothyroidism, hyperthyroidism) prior to starting dialysis.
• • Recent Thyroid Treatment: Patients who have received treatment for thyroid dysfunction (e.g., thyroid hormone replacement, antithyroid medications) within the last six months.
• • Patients with acute kidney injury (AKI) or those who are not on regular dialysis.
• • Pregnant or lactating women.
• • Patients with systemic illnesses or medications that could interfere with thyroid function tests (e.g., corticosteroids, lithium).